Inmune Bio Inc (INMB)
NASDAQ:INMB
Holding INMB?
Track your performance easily

Inmune Bio (INMB) Financial Statements

294 Followers

Inmune Bio Financial Overview

Inmune Bio's market cap is currently ―. The company's EPS TTM is $-2.06; its P/E ratio is -3.37; Inmune Bio is scheduled to report earnings on October 30, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 14.00K$ 28.00K$ 43.00K$ 46.00K
Gross Profit-$ 14.00K$ 28.00K$ 43.00K$ 46.00K
EBIT$ -9.50M$ 10.68M$ -8.38M$ 559.47M$ -5.78M
EBITDA$ -9.47M$ 10.71M$ -8.38M$ 559.53M$ -5.72M
Net Income Common Stockholders$ -9.75M$ -11.00M$ -8.41M$ -8.53M$ -6.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 31.07M$ 26.00M$ 35.85M$ 41.81M$ 47.83M
Total Assets$ 52.45M$ 46.83M$ 57.00M$ 62.70M$ 69.72M
Total Debt$ 5.43M$ 7.94M$ 10.44M$ 12.91M$ 15.39M
Net Debt$ -25.64M$ -18.06M$ -25.41M$ -28.90M$ -32.44M
Total Liabilities$ 16.03M$ 17.81M$ 18.86M$ 17.97M$ 19.07M
Stockholders Equity$ 36.28M$ 28.22M$ 37.34M$ 43.93M$ 50.65M
Cash Flow-
Free Cash Flow$ -7.90M$ -7.50M$ -3.40M$ -4.26M$ -3.16M
Operating Cash Flow$ -7.90M$ -7.50M$ -3.40M$ -4.26M$ -3.16M
Investing Cash Flow-----
Financing Cash Flow$ 13.00M$ -2.50M$ -2.50M$ -1.73M-
Currency in USD

Inmune Bio Earnings and Revenue History

Inmune Bio Debt to Assets

Inmune Bio Cash Flow

Inmune Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis